A detailed history of Bell Bank transactions in Viatris Inc stock. As of the latest transaction made, Bell Bank holds 423,689 shares of VTRS stock, worth $5.25 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
423,689
Previous 485,119 12.66%
Holding current value
$5.25 Million
Previous $5.16 Million 4.6%
% of portfolio
0.59%
Previous 0.44%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$10.32 - $12.13 $633,957 - $745,145
-61,430 Reduced 12.66%
423,689 $4.92 Million
Q2 2024

Jul 31, 2024

SELL
$10.05 - $12.02 $36,732 - $43,933
-3,655 Reduced 0.75%
485,119 $5.16 Million
Q1 2024

Apr 23, 2024

SELL
$11.27 - $13.53 $75,880 - $91,097
-6,733 Reduced 1.36%
488,774 $5.84 Million
Q4 2023

Jan 22, 2024

SELL
$8.77 - $10.85 $70,800 - $87,592
-8,073 Reduced 1.6%
495,507 $5.37 Million
Q3 2023

Oct 30, 2023

SELL
$9.59 - $11.35 $76,202 - $90,187
-7,946 Reduced 1.55%
503,580 $4.97 Million
Q2 2023

Jul 26, 2023

SELL
$9.02 - $10.29 $235,845 - $269,052
-26,147 Reduced 4.86%
511,526 $5.11 Million
Q1 2023

Apr 19, 2023

SELL
$9.2 - $12.26 $147,678 - $196,797
-16,052 Reduced 2.9%
537,673 $5.17 Million
Q4 2022

Jan 31, 2023

SELL
$8.72 - $11.56 $100,995 - $133,887
-11,582 Reduced 2.05%
553,725 $6.16 Million
Q3 2022

Oct 11, 2022

BUY
$8.48 - $11.13 $545,416 - $715,859
64,318 Added 12.84%
565,307 $4.82 Million
Q2 2022

Jul 15, 2022

BUY
$9.95 - $12.27 $27,034 - $33,337
2,717 Added 0.55%
500,989 $5.25 Million
Q1 2022

Apr 25, 2022

BUY
$9.81 - $15.4 $3.68 Million - $5.78 Million
375,318 Added 305.25%
498,272 $5.42 Million
Q4 2021

Feb 01, 2022

BUY
$12.09 - $14.68 $1.49 Million - $1.8 Million
122,954 New
122,954 $1.66 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Bell Bank Portfolio

Follow Bell Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bell Bank with notifications on news.